Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials
Shuxin Luan,1 Hongquan Wan,1 Shijun Wang,1 He Li,2 Baogang Zhang3 1Department of Mental Health, 2Department of Pain Medicine, The First Hospital of Jilin University, 3Department of Endoscopy, China-Japan Union Hospital of Jilin University, Changchun, People’s Republic of China Background...
Guardado en:
Autores principales: | Luan S, Wan H, Wang S, Li H, Zhang B |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/71c5562f3ec648a5a2a3535bbee46ab2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study
por: Wang G, et al.
Publicado: (2016) -
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Luan SX, et al.
Publicado: (2018) -
Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial
por: Che T, et al.
Publicado: (2018) -
The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
por: Li G, et al.
Publicado: (2016) -
A Preliminary Randomized Controlled Trial of Different Treatment Regimens for Melancholic Depression
por: Wang Y, et al.
Publicado: (2021)